# RGSL1

## Overview
RGSL1, or regulator of G protein signaling like 1, is a gene that encodes a protein belonging to the Regulator of G Protein Signaling (RGS) family. This family of proteins is integral to the modulation of G protein-coupled receptor (GPCR) signaling pathways, which are pivotal in various cellular processes such as growth, differentiation, and movement. The RGSL1 protein functions as a GTPase-activating protein (GAP) for Gα subunits, facilitating the inactivation of G proteins by accelerating the hydrolysis of GTP to GDP (Li2023RGS). Structurally, RGSL1 contains an RGS homology (RH) domain, which is crucial for its interaction with G protein alpha subunits and other signaling molecules (Tesmer2009Chapter). The gene has been implicated in cancer, particularly breast cancer, where it exhibits altered expression and methylation patterns, suggesting a role in tumorigenesis (Wu2024Pancancer). Despite its potential significance in cancer, the precise physiological role of RGSL1 in normal human cells remains to be fully understood.

## Structure
The RGSL1 protein is part of the Regulator of G Protein Signaling (RGS) family, which is involved in modulating G protein-coupled receptor (GPCR) signaling. It contains an RGS homology (RH) domain, a conserved structural feature that facilitates protein-protein interactions, often with G protein alpha subunits (Tesmer2009Chapter). The RH domain is characterized by a bundle of nine helices forming a nonglobular structure with two lobes, known as the 'bundle subdomain' and the 'terminal subdomain' (Tesmer2009Chapter). This domain is versatile and can interact with various targets, although not all RH domains directly interact with G protein alpha subunits (Tesmer2009Chapter).

The RGSL1 gene has been studied in the context of breast cancer, where high-resolution melting analysis identified three tumor-specific missense mutations, suggesting potential functional implications in cancer progression (Wiechec2011HighResolution). These mutations include G664A, C2262G, and C2316T, which result in amino acid changes Val222Ile, Asp754Glu, and Ser772Leu, respectively (Wiechec2011HighResolution). The RH domain's adaptability and potential for interaction with diverse proteins make it a target for drug design, aiming to disrupt these interactions (Tesmer2009Chapter). However, specific details about the tertiary and quaternary structures of RGSL1 are not provided in the available context.

## Function
RGSL1 (regulator of G protein signaling like 1) is involved in modulating G protein-coupled receptor (GPCR) signaling pathways. It functions as a GTPase-activating protein (GAP) for Gα subunits, accelerating the hydrolysis of GTP to GDP, which inactivates the G protein. This regulation is crucial for controlling signal transduction, affecting various cellular processes such as cell growth, differentiation, and movement (Li2023RGS). RGSL1 is typically active in the cytoplasm, where it interacts with GPCRs and other signaling molecules (Li2023RGS).

In the context of cancer, RGSL1 has been observed to have altered expression and methylation patterns. It is differentially expressed in various cancers, including breast cancer (BRCA), kidney renal clear cell carcinoma (KIRC), lung adenocarcinoma (LUAD), and lung squamous cell carcinoma (LUSC) (Wu2024Pancancer). RGSL1 is hypomethylated in several cancers, suggesting its dysregulated expression may contribute to tumorigenesis (Wu2024Pancancer). In breast cancer, genomic alterations in the region containing RGSL1 have been associated with allelic imbalance, which may influence the transcriptional regulation of the gene (Wiechec2008A). However, the specific function of RGSL1 in healthy human cells remains to be fully elucidated.

## Clinical Significance
Mutations in the RGSL1 gene have been implicated in breast cancer. High-resolution melting (HRM) analysis identified three novel missense mutations in the RGSL1 gene, specifically G664A (Val222Ile) in exon 6, C2262G (Asp754Glu), and C2316T (Ser772Leu) in exon 13. These mutations were found exclusively in breast tumor samples and not in the blood DNA of the same patients, suggesting a potential association between RGSL1 mutations and breast cancer (Wiechec2011HighResolution). 

The RGSL1 gene is located in the 1q25.3 region, a site known for genomic instability in breast cancer. Studies have shown a high rate of allelic imbalance (AI) in this region, with chromosomal breakpoints and microdeletions affecting RGSL1, which may contribute to breast cancer susceptibility and progression (Wiechec2008A). Although the specific function of RGSL1 in cancer is not fully established, its strong homology to other RGS family members and its expression in breast tissue suggest it as a candidate gene for breast cancer (Wiechec2008A). These findings highlight the potential role of RGSL1 in the development and progression of breast cancer.


## References


[1. (Li2023RGS) Lin Li, Qiang Xu, and Chao Tang. Rgs proteins and their roles in cancer: friend or foe? Cancer Cell International, April 2023. URL: http://dx.doi.org/10.1186/s12935-023-02932-8, doi:10.1186/s12935-023-02932-8. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12935-023-02932-8)

[2. (Wiechec2008A) Emilia Wiechec, Jens Overgaard, and Lise Lotte Hansen. A fragile site within the hpc1 region at 1q25.3 affecting rgs16, rgsl1, and rgsl2 in human breast carcinomas. Genes, Chromosomes and Cancer, 47(9):766–780, June 2008. URL: http://dx.doi.org/10.1002/gcc.20578, doi:10.1002/gcc.20578. This article has 23 citations.](https://doi.org/10.1002/gcc.20578)

[3. (Wiechec2011HighResolution) Emilia Wiechec, Carsten Wiuf, Jens Overgaard, and Lise Lotte Hansen. High-resolution melting analysis for mutation screening of rgsl1, rgs16, and rgs8 in breast cancer. Cancer Epidemiology, Biomarkers &amp; Prevention, 20(2):397–407, February 2011. URL: http://dx.doi.org/10.1158/1055-9965.epi-10-0514, doi:10.1158/1055-9965.epi-10-0514. This article has 11 citations.](https://doi.org/10.1158/1055-9965.epi-10-0514)

4. (Wu2024Pancancer) Pan-cancer multi-omics analysis reveals the prognostic value of RGS gene family. This article has 0 citations.

[5. (Tesmer2009Chapter) John J.G. Tesmer. Chapter 4 Structure and Function of Regulator of G Protein Signaling Homology Domains, pages 75–113. Elsevier, 2009. URL: http://dx.doi.org/10.1016/S1877-1173(09)86004-3, doi:10.1016/s1877-1173(09)86004-3. This article has 77 citations.](https://doi.org/10.1016/S1877-1173(09)86004-3)